BioSpace News Archive

Apellis Pharmaceuticals today announced that the company will host a conference call and webcast to discuss its third quarter 2021 financial results on Monday, November 8, 2021 at 4:30 p.m. ET.

Antibe Therapeutics Inc. is pleased to provide further detail on otenaproxesul’s development plan for acute pain indications.

Zogenix today announced that it will host a key opinion leader (KOL) webinar on thymidine kinase 2 deficiency (TK2d) and MT-1621 on Monday, November 8, 2021, at 12:00 PM Eastern Time.

Avadel Pharmaceuticals plc announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, November 8, 2021, to provide a corporate update and discuss the Company’s financial results for the third quarter ended September 30, 2021.

CytomX Therapeutics, Inc. today announced that preclinical data for a conditionally activated interferon alpha-2b (IFN-a2b) will be presented at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting (SITC 2021)

Kymera Therapeutics, Inc. today announced that the Company will participate in several upcoming virtual investor conferences:

Candel Therapeutics, Inc. today announced its participation in upcoming medical and scientific conferences.

Lipocine Inc. (NASDAQ: LPCN), announced today that three abstracts have been selected for poster presentations during the upcoming The Liver Meeting® 2021, organized by the American Association for the Study of Liver Diseases (AASLD) to take place November 12-15, 2021.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it presented new data from its movement disorder program for tardive dyskinesia (TD) at the 2021 Psych Congress scientific meeting being held October 29–November 1, 2021.

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that new microbiome data from its Phase 2a clinical trial for C. difficile Infection (CDI) will be presented at the 9th Annual International C. diff Conference & Health Expo. taking place virtually on November 4-5, 2021.